Fig. 1.

Overview of brain tumor modeling using genome engineering. Introducing brain-tumor-associated mutations into human stem cells, cerebral organoids, or mouse embryonic brains give rise to various brain tumor models that can be utilized for histological, genomic analyses, and search for novel therapeutic targets. These models allow comparative functional assessment of particular genetic alterations in otherwise isogenic backgrounds.